The androgen receptor: Functional structure and expression in prostate tumors
✍ Scribed by Trapman, J.; Faber, P.W.; Ris-Stalpers, C.; van Laar, C.; de Winter, K.Ruizeveld; Zegers, N.; Schröder, F.H.; van der Kwast, Th.H.; Mulder, E.; Brinkmann, A.O.
- Book ID
- 122578427
- Publisher
- Elsevier Science
- Year
- 1990
- Weight
- 130 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0277-5379
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## BACKGROUND. Endocrine therapy for prostate cancer aims to reduce the levels of circulating androgen or to inhibit androgen action by blocking the androgen receptor in the prostate, or both. Studies in various animal and human prostate cancer models suggested that there may be a downregulation o
## Abstract Human prostate cancer (PC) overexpresses the gastrin‐releasing peptide receptor (GRPR). Radiolabeled GRPR‐targeting analogs of bombesin (BN) have successfully been introduced as potential tracers for visualization and treatment of GRPR‐overexpressing tumors. A previous study showed GRPR
## Abstract Background: Androgen receptors (AR) are expressed in human prostate cells and immunohistochemistry has been used for qualitative analysis of AR expression in prostate tumor cells. Quantitative and multiparametric analysis of receptor expression could be of diagnostic and prognostic valu